Impact of disease severity on outcome of antiviral therapy for chronic hepatitis C: Lessons from the HALT-C trial.
Everson GT, Hoefs JC, Seeff LB, Bonkovsky HL, Naishadham D, Shiffman ML, Kahn JA, Lok AS, Di Bisceglie AM, Lee WM, Dienstag JL, Ghany MG, Morishima C; HALT-C Trial Group.
Everson GT, et al. Among authors: seeff lb.
Hepatology. 2006 Dec;44(6):1675-84. doi: 10.1002/hep.21440.
Hepatology. 2006.
PMID: 17133499
Free article.
Clinical Trial.